GeNeuro SA (GNRO.PA)

EUR 0.06

(-4.72%)

Long Term Debt Summary of GeNeuro SA

  • GeNeuro SA's latest annual long term debt in 2023 was 6.49 Million EUR , up 1169.52% from previous year.
  • GeNeuro SA's latest quarterly long term debt in 2023 FY was 6.49 Million EUR , up 1169.52% from previous quarter.
  • GeNeuro SA reported annual long term debt of 511.39 Thousand EUR in 2022, up 19735.51% from previous year.
  • GeNeuro SA reported annual long term debt of 2578.20 EUR in 2021, up 1886.29% from previous year.
  • GeNeuro SA reported quarterly long term debt of 6.49 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • GeNeuro SA reported quarterly long term debt of 6.34 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of GeNeuro SA (2023 - 2013)

Historical Annual Long Term Debt of GeNeuro SA (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 6.49 Million EUR 1169.52%
2022 511.39 Thousand EUR 19735.51%
2021 2578.20 EUR 1886.29%
2020 129.80 EUR -29.03%
2019 182.90 EUR -1.77%
2018 186.20 EUR -13.4%
2017 215.00 EUR 33.13%
2016 161.50 EUR -8.34%
2015 176.20 EUR -99.9%
2014 169.4 Thousand EUR -3.86%
2013 176.2 Thousand EUR 0.0%

Peer Long Term Debt Comparison of GeNeuro SA

Name Long Term Debt Long Term Debt Difference
ABIONYX Pharma SA 1.1 Million EUR -489.673%
ABIVAX Société Anonyme 44.69 Million EUR 85.475%
Adocia SA 4.54 Million EUR -43.002%
Aelis Farma SA 2.04 Million EUR -217.007%
Biophytis S.A. 3.11 Million EUR -108.689%
Advicenne S.A. 15.89 Million EUR 59.158%
genOway Société anonyme 5.51 Million EUR -17.629%
IntegraGen SA 642.28 Thousand EUR -910.821%
Medesis Pharma S.A. 1.2 Million EUR -441.025%
Neovacs S.A. 650 Thousand EUR -898.815%
NFL Biosciences SA 39.2 Thousand EUR -16460.722%
Plant Advanced Technologies SA 4.35 Million EUR -49.025%
Quantum Genomics Société Anonyme 1.96 Million EUR -231.184%
Sensorion SA 1.24 Million EUR -423.188%
Theranexus Société Anonyme 2.46 Million EUR -163.838%
TME Pharma N.V. - EUR -Infinity%
Valbiotis SA 3.89 Million EUR -66.555%
TheraVet SA 1 Million EUR -548.841%
Valerio Therapeutics Société anonyme 6.9 Million EUR 5.99%
DBV Technologies S.A. 4.52 Million USD -43.445%
Genfit S.A. 62.25 Million EUR 89.571%
Innate Pharma S.A. 30.6 Million EUR 78.788%
Inventiva S.A. 25.61 Million EUR 74.655%
MaaT Pharma SA 5.42 Million EUR -19.674%
MedinCell S.A. 52.8 Million EUR 87.704%
Nanobiotix S.A. 41.66 Million EUR 84.416%
OSE Immunotherapeutics SA 35.5 Million EUR 81.716%
Poxel S.A. 40.14 Million EUR 83.827%
GenSight Biologics S.A. 1.04 Million EUR -519.494%
Transgene SA 17 Thousand EUR -38090.0%
Valneva SE 132.76 Million EUR 95.11%